WallStSmart
AVIR

Atea Pharmaceuticals Inc

NASDAQ: AVIR · HEALTHCARE · BIOTECHNOLOGY

$5.51
+1.47% today

Updated 2026-04-30

Market cap
$435.81M
P/E ratio
P/S ratio
1.55x
EPS (TTM)
$-1.94
Dividend yield
52W range
$2 – $6
Volume
0.5M

Atea Pharmaceuticals Inc (AVIR) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-12.1%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-42.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+8.5%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+16.0%
2026-03-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-06$-0.57-17.5%$5.30$6.15+16.0%
2025-11-06$-0.53-26.2%$3.24$3.27+0.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.49$-0.57-17.5%
2025-09-30$-0.42$-0.53-26.2%
2025-06-30$-0.41$-0.44-7.3%
2025-03-31$-0.41$-0.40+2.4%
2024-12-31$-0.29$-0.40-38.1%$416000.00
2024-09-30$-0.49$-0.37+24.5%
2024-06-30$-0.76$-0.48+36.8%
2024-03-31$-0.61$-0.75-23.0%
2023-12-31$-0.50$-0.47+6.0%
2023-09-30$-0.48$-0.40+16.7%
2023-06-30$-0.47$-0.34+27.7%
2023-03-31$-0.48$-0.43+10.4%

Frequently asked questions

Has Atea Pharmaceuticals Inc beaten earnings estimates?
Atea Pharmaceuticals Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -12.1% over the last 4 quarters.
How does AVIR stock react to earnings?
AVIR stock has moved an average of +8.5% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.